Kala Pharmaceuticals (KALA) Investor Presentation (Slideshow)
Innovation In Ophthalmology Corporate Overview January 2022 NOT FOR PROMOTIONAL USE Disclaimers and Notices This presentation contains forward-looking statements that involve substantial risks and uncertainties. Any statements in this presentation about our future expectations, plans and prospects, including but not limited to statements about our expectations with respect to and potential advantages of KPI-012, KPI-287 and our SEGRM program, the future development or commercialization of KPI-012, KPI-287 o ...